Pfizer and his German partner Biontech lost their proposals to cancel the Covid-19 vaccine in the London Court of Appeals.
Last year, the Supreme Court said that one of the patents of the Modernology related to RNA (MRA) technology related to the Covid-19 vaccine, and Moderna, who violated him, was damaged in sales after March 2022.
The Supreme Court also managed to invalidate the other modern patent under the difficulties. Moderna was rejected permission to complain about this decision.
However, Pfizer and Biontech were allowed to complain against the second patent of this month and invalidate, and this month ago, this month was the open developments of the previous work by dispute the development of MRNNA technology.
Judge Richard Arnold rejected Pfizer and Biontech’s application.
Pfizer and Biontech said the decision “decision” and the companies will try to complain about the decision, “that this patent is invalid.”
“This decision does not immediately affect Pfizer and Biontech or Comirnaty,” companies added.
Moderna did not respond immediately to a request for comment.
Friday’s decision between the two parties in the legitimate dispute between the two sides between the two sides, which competes in the legal dispute between competing vaccines that helped save millions of people during the pandemic.
The companies also took part in the trial in Germany, which managed the sympathy of the court in the Patent Office of the United States of the United States, these two modern Covid-19 vaccine paters were invalid and elsewhere.
-Sam Tobin, Reuters